Amp Regulated

Amp Regulated

The role of histamine in the mentally ill and its attenuation by vitamin C – Part III

Chapter 5: Conclusions, Implications and recommendations for future research

Conclusions and implications:

The role of histamine in mental illness has been theorized for several decades, but both conventional and alternative medical fields have been slow to observe the influence of histamine in mental health. In addition, the vast majority of conventional and alternative practitioners are unaware that vitamin C has potent effects antihistamine, which may be beneficial to both physical and mental health. The conventional medicine antihistamines used to treat histamine-related pharmaceutical physical complaints, and sometimes mental. As mentioned above, pharmaceutical antihistamines have several side effects, many of which are in poorer health mental. It is unfortunate that the vast majority of medical alternatives are ignorant of the effects of vitamin C antihistamine. It is the purpose of this thesis to convey the effects of antihistamines, vitamin C, especially as regards treatment of various forms of mental illness.

Proof of the positive impact of the vitamin C on mental health is convincing. Vitamin C can act as a mild antidepressant by increasing levels of cAMP. Low levels of cAMP are associated with depression. Vitamin C also helps to produce norepinephrine, which, as the camp is often low in depression. Indeed, The camp is down the path of norepinephrine, which is how many antidepressant drug used to improve mood. Vitamin C hydroxy dopamine also to help train norepinephrine (Goodman et al., 1996).

Vitamin C, when used at high doses, which may reduce anxiety (Balch and Balch, 1997). As mentioned previously, the brain is constantly maintained constant levels of vitamin C, no matter how low levels are in the rest of the body. Thus, the question arises: how can the low levels of vitamin D or high health mental, if not in a constant concentration in the brain? A possible explanation is as follows: the group of Vitamin C Total Body may become more oxidized than reduced. Note that only oxidized vitamin C enters the brain, where it is reduced. If insufficient reducing agents into the brain, then oxidized Vitamin C remain, as most of its properties rendered useless. Reduction of vitamin C modulates levels of dopamine in the brain, and therefore both can act as an antipsychotic Natural reducing high levels of dopamine. It also helps to secrete oxytocin, a hormone of pleasure, hence the improvement mood. As mentioned above, "the promotion of ascorbate formation of myelin (Rice, 2000, p. 214). Vitamin C also inhibits release of the stress hormone cortisol, which over long periods can precipitate depression. It also helps protect the brain against neurotoxicity induced by the drug, probably by its antioxidant effects.

However, by far the largest positive effect on mental health than vitamin C has an antihistamine effect. This is because, as mentioned above, histamine has several adverse effects on mental health. Administration of histamine in the brains of animals enhanced fear memory (Blandina et al., 2004). It is well known that histamine plays a role important in allergic reactions, and people with allergies are much more likely to suffer from depression (Firshein, 1996; Ossofsky, 1976). Histamine can directly cause depression behavior (Arrigo-Reina and Chiechio, 1998).

As mentioned above, histamine, either directly or indirectly influence all neurotransmitters main, often by inhibiting the release of neurotransmitters (Brown, Stevens, and Haas, 2001), which theoretically causing anxiety, depression, or both. Anxiety can be caused by inhibition of histamine, GABA, which decreases nerve transmission. Depression can be caused by inhibition of the antidepressant "neurotransmitters serotonin and noradrenaline. However, histamine can also release norepinephrine (Bugajski, 1984) with it causing anxiety or mania. Often Stress releases histamine, which in turn will help unlock the HPA axis stress hormones. It is known that chronic activation HPA is associated with depression and disorders of the brain. There is also evidence that histamine activated via the track more calcium than DAG (Sarri, croutons, and Claro, 1995). There is abundant evidence that the DAG path is an antidepressant type, and the calcium channel can cause depression.

In addition to its antihistamine effect, there are several sources of evidence that suggests that humans should take supplements of vitamin C. Dr. Linus Pauling, twice Nobel Laureate, believes that adults need between man and nine grams of vitamin C per day (Haas, 1992). Animals are the synthesis of vitamin C can make 45-300 times the RDA adult human is about 0.9 mg / kg / day (60-90 mg / day) (Levine, 1985). To be a 150-pound human, this extrapolated to about 12 grams per day, if human beings synthesize their own vitamin C. Vitamin C blood and tissues decreases with age (Lieberman and Bruning, 1997), which is another reason to complete. If vitamin C is considered as a supplement supplements should then consider others, because the requirements of vitamin C in calcium, magnesium, bioflavonoids, and help its own assimilation (Balch and Balch, 1997).

Recommendations for future research:

Because vitamin C and histamine are involved in both physical processes and mentally, which leads to the question of psychosomatic problems and the two molecules. Recall that the two molecules are also involved in the response immune and pro-or anti-allergic responses. There are three possible links between psychological and somatic state of allergy. The first is that allergies are caused by psychological stress. The second is that psychological stress is caused by allergies. The third is that exposure can produce answers allergic to both psychological and somatic. This third link has been demonstrated in a double blind study (King, 1981). As mentioned above, the release of histamine-mediated allergy is associated with several mental reactions.

There have been various theories about the molecular basis mental illness for several decades. The first theory is called the theory monoamines formed in 1950 and 1960. It is suggested that brain abnormal is directly dependent on the fluctuating levels of monoamine (serotonin, norepinephrine, dopamine, GABA). Interestingly, histamine did not appear not in the theory of monoamine origin, probably due to the lack of investigation both as to its effects on mental health. At that time, Most doctors usually give antidepressants for depressed patients only, and benzodiazepines (eg Xanax, Valium) for Anxious. The second theory is the theory of comorbidity, psychiatric philosophy that dominated the 1990s. It was formed following the recognition Medications like Prozac, without the aid can reduce depression and anxiety. The third is the subsyndromal theory, which has evolved the discovery that vast majority of people want to experience depression, and vice versa. The philosophy of the theory is essentially in subsyndromal the middle of the monoamine theories and comorbidity.

The discovery that histamine can inhibit all the other important neurotransmitters suggests take another look at the monoamine hypothesis behind the mental illness. It is known that dopamine tends to be high in psychotic mania noradrenaline serotonin in the high and low in depression. One might assume that the psychotic dopamine neurotransmitter system have dominated the neurotransmitter norepinephrine Bipolar dominated, and serotonin, a neurotransmitter system depressant dominated. The fourth major monoamine, histamine, may be dominant in atopic (allergic) individuals. People mainly histaminergic neurotransmitter systems could have a wide variety of mental illnesses, and that histamine affects the release of all the most important neurotransmitters. Biochemical characterization of histamine person may be of interest to professionals to help that person physically and mentally. This characterization leads to the question of writing described metabolic below.

In emerging nutrition science writing metabolic calls for a series of questions to determine what type of Biochemistry have. Some people are slow oxidizers tend to be dominant in the sympathetic system. They get better results in carbohydrates. Other are fast oxidizers tend to be the dominant parasympathetic nervous system. These people do better with more fat and protein in your diet. Too many carbs during rapid oxidation can lead to many physical and mental problems. Since histamine is a stimulant molecule, which can accelerate the oxidation, and histamine types may want to consider limiting carbohydrates.

There is some evidence to suggest that histamine is involved in the creation of biochemistry parasympathetic dominant person. The parasympathetic branch of the central nervous system is responsible the decrease in heart rate and an increase in digestive secretions of which are also caused by the release of histamine. In addition, the dominant trends of physics parasympathetic allergies and overfeeding (Wolcott and Fahey, 2002). Histamine is a major cause of allergies and its stimulating effect on digestion can lead to excessive eating.

In addition to its antihistamine effect, Vitamin C can help to Biochemistry a person in another, more subtle. Vitamin C can be purchased as ascorbic acid or right neutral pH calcium ascorbate or ascorbate sodium. For those who are sympathetic dominant, right ascorbic acid should be considered, since the types of people do not have enough fluids hydrochloric acid. Hydrogen ascorbic acid dissociate weakly bound hydroxyl group in the stomach and facilitate digestion of proteins. Acid ascorbic acid may also be useful for balancing the pH of the blood of people with metabolic alkalosis.

In contrast, the parasympathetic system, which tend to have a strong production of hydrochloric acid, calcium ascorbate should try and accept that the ions of excess ascorbate hydrogen in the stomach. Calcium ascorbate at high doses can help neutralize acid reflux. Calcium is also good for parasympathetic in delaying oxidation (Wolcott and Fahey, 2002). calcium ascorbate can help balance the pH of the blood of people who have metabolic acidosis.

Other future research could focus on how megadoses of vitamin C affects the mental health quantitatively. There has been some research showing that consumption of vitamin C improves mood (Brody, 2002; Balch and Balch, 1997). So far, there has been a large study to see whether vitamin C alone can reduce significant depression or anxiety, either in conventional medicine or alternative. There are two main clinical scales measure depression and anxiety scale — Hamilton Depression and Hamilton Anxiety Scale. It would be interesting see if vitamin C could significantly reduce depression alone and / or anxiety.

Because people have different atoms crooked different, the question arises how much vitamin C is needed daily by a person for the physical and mental health. One of the best ways assess the amount of vitamin C a person needs is to do their hunting ascorbic acid. This can be done both acid ascorbic acid and calcium ascorbate, sodium /. The protocol may vary, but usually comprises a person who takes 1-2 grams of vitamin C every hour until the Tolerance is colon (diarrhea). The grams of vitamin C are counted and recorded. The final program (s) that cause intestinal tolerance generally multiplied by 50-80%, which is the daily dose of reference, you should take next. For example, if 18 grams of tolerance allows intestine, 9.16 grams is the amount reference daily. If the person is under an unusual amount of stress or a viral infection, the baseline can be increased to bowel tolerance occurs at a higher level than before. Again, the new temporary intestinal tolerance is lowered to a certain percentage of the agent stress decreases.

Abstract:

The contents of this thesis has developed a multidimensional model for the attenuation mental illness associated with histamine by vitamin C. Both histamine and vitamin C on the human body at multiple levels. Histamine plays many different roles in the body, including neuromodulation, neurotransmission, mediated allergic inflammatory mediator and stimulator of the secretion gastric acid. When histamine levels are within normal range, the above process are generally balanced and functioning optimally. This is when histamine levels are very low or high, problems may occur. One function of vitamin C in the body is to modulate the levels histamine, and if the low levels of histamine, the administration of vitamin C will make small quantities of histamine to be released. When histamine levels are abnormally high, vitamin C acts as an antihistamine, to destroy excess histamine and that this chemical to normal physiological levels.

In addition to its antihistamine, vitamin C has many other actions in the body. Like histamine, Vitamin C is also a neuromodulator, and as an immunomodulator. In fact, on the basis of the above information in this thesis is not an exaggeration to that vitamin C is the counterpart of histamine and molecular surveillance. Unfortunately for humans, vitamin C can not be synthesized in the body, so it must be filled in foods or nutritional supplements. If humans could synthesize vitamin C, a person would be about £ 150 12 grams of vitamin C per day. It is 133-200 times more U.S. (RDA) for vitamin C. This statistic does highlight the fact that there is a huge difference between the RDA of vitamin C to prevent rare diseases, and maintain optimum physical and mental health.

suboptimal amounts of vitamin C in the blood and tissue histamine can allow dangerous levels. Histamine is competing with other neurotransmitters and excess histamine can control and inhibition of other neurotransmitters. This can lead to anxiety and depression. Histamine release both norepinephrine and dopamine, and these two neurotransmitters Beyond may precipitate mania and psychosis, respectively. Histamine can also be involved in AD (Passani, Bacciottini, Mannaioni, and Blandine, 2000). Stress releases histamine, which in turn releases a number of hormones Stress can cause serious injury if stress is chronic. The histamine and other neurotransmitters dominates, may also deregulate HPA axis by stimulating the pituitary and adrenal glands.

The molecule cyclic AMP (cAMP) is an important regulator metabolism. Intense allow the maintenance of physical and mental health. Low levels can cause asthma, depression, and perhaps even cancer. Histamine decreases the levels of cAMP by a mechanism that is not fully clarified, because it may have to do with the antagonist calcium through cAMP. Vitamin C increases the levels of cAMP for at least three methods: direct histamine degrading cAMP synergy with producers, and inhibiting the enzyme (phosphodiesterase) that degrades cAMP. This way, you can reduce, prevent or reverse asthma, depression and cancer. Vitamin C also helps to reverse asthma by preventing the synthesis of inflammatory mediators of arachidonic acid (AA) and PGF2a. CAMP also inhibits the release of histamine (Mohsenin and Dubois, 1987).

It has been demonstrated in this thesis that Vitamin C is very beneficial for mental health in different ways. Benefits of Vitamin C Mental Health, both antihistamines and their effects in many other ways too. It is very unfortunate that humans can not synthesize their own vitamin C. The animals that synthesize their own cancer of vitamin C much less than humans. However, the recommended daily dose of vitamin C is a miserable 60-90 mg / day, just enough to prevent certain diseases which are rare in developed countries. The time will come when vitamin C is recommended by doctors and nutritionists at doses that are appropriate weight Single Occupancy — about eight grams per 100 pounds, twice as suggested by Nobel laureate Linus Pauling.

References

Abbas, A., Lichtman, A., & Pober, J. (2000). Cellular and Molecular Immunology (4th ed).. New York: WB Saunders Company.

Abdulla, Y., and Hamadah, K. (1970). 3 '-monophosphate 5'en depression and mania adenosine. Lancet, 1, 378-381.

Agus, D., Gambhir, S., Pardridge, W., Spielholz, C., Baselga, J., J. Vera, et al. (1997). Vitamin C crosses the blood-brain barrier in oxidized form by glucose transporters. Journal of Clinical Investigation, 100, 2842-2848.

Anderson, K., Means, R., Huang, QH., Kemp, B., and Goldstein, E. (1998). Components of a cascade of calmodulin protein kinase: molecular cloning, functional characterization and localization Cellular Ca2 + / calmodulin-dependent protein kinase beta. Journal of Biological Chemistry, 273, 31880-31889.

Aprison, M., Takahashi, R. & Tachiki, K. (1978). Hypersensitive serotonergic receptors involved in clinical depression — a theory. Neuropharmacology and behavior. New York: Plenum Press.

Arora, R., & Meltzer, H. (1989). Increase serotonin2 (5-HT2) receptor binding as measured by diethylamide of lysergic acid-3H (3H-LSD) in blood platelets of depressed patients. Life Sciences, 44, 725-734.

Arrigo-Reina, R. Chiechio & S. (1998). Evidence of a key role for histamine from mast cells in the analgesic effect of clomipramine rats. Inflammation Research 47, 44-48.

Axelrod, J., & Reisin, T. (1984). Stress hormones: their interaction and regulation. Science, 224, 452-459.

Balch, J., & Balch, P. (1997). Prescription for Nutritional Healing, 2nd edition. Garden City Park: Avery Publishing Group.

Banhegyi, G. Braun, L., Gwage, M., Puskas, F., & Mandl, J. (1997). Ascorbate metabolism and its regulation animals. Free Radical Biology and Medicine, 23, 793-803.

Bielkiewicz-Vollrath, B., Carpenter, J., Schulz, R., & Cook, D. (1987). At the start of production Inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate by histamine and carbachol in smooth muscle ileal. Molecular Pharmacology, 31, 513-522.

Bito, H., Deisseroth, K., & R. Tsien (1996). phosphorylation and dephosphorylation CREB: a stimulus and switch +-dependent Ca2 duration of gene expression in the hippocampus. Cell, 87, 1203-1214.

Blandina, P., Efoudebe, M., Cenni G, Mannaioni, P., & Passani, M. (2004). Acetylcholine, histamine, and cognition: two sides of same coin. Learning and Memory, 11, 1-8.

Boeing, H., & Rausch, E. (1996). Ascorbic acid and disease Chronic: what is the evidence? Subcellular Biochemistry, 25, 117-136.

Bongers G., Leurs, R., Robertson, J. & Raber, J. (2004). Role H3 receptor-mediated signaling in anxiety and cognition in the wild type and ApoE-/ – Mice. Neuropsychopharmacology, 29, 441-449.

Brody, S. (2002). High-dose frequency of reports of ascorbic acid increases and improves mood: a randomized controlled trial. Biological Psychiatry, 52, 371-374.

Brody, S., Preut, R., Schommer, K., & Schurmeyer, T. (2002). A randomized controlled high doses of ascorbic acid to reduce blood pressure, cortisol, and subjective responses to psychological stress. Psychopharmacology, 159, 319-324.

Brown, A., Malling, A., & Renbaum, L. (1993). Elevated platelet membrane phosphatidylinositol-4 ,5-bisphosphate in mania bipolar. American Journal of Psychiatry, 150, 1252-1254.

Brown, R., Stevens, D., & Haas, H. (2001). The physiology of histamine brain. Progress in Neurobiology, 63, 637-672.

Bugajski, J., & Gadek, A. (1983). Central-histamine H1 and H2 stimulation of the cortex adrenal stress response in rat pituitary. Neuroendocrinology, 36, 424-430.

Bugajski, J. (1984). Central and pituitary adrenal stimulation action of the metabolism of histamine and clonidine. Polish Journal of Pharmacology and Pharmacy, 36, 159-176.

Buses, R., Halfon, N., Benjamin B., & Wells, K. (1995). The prevalence of behavior problems among American children suffering from asthma. Archives of Pediatrics & Adolescent Medicine, 149, 565-572.

Calam, R., Gregg, L., Simpson, B., Morris, J., Woodcock, A., et al. (2003). Childhood asthma, behavior problems and family functioning. Journal of Allergy and Clinical Immunology, 112, 499-504.

Cameron E. and Pauling, L. (1993). Cancer and Vitamin C. Philadelphia: Camino Books.

Cantu, T., & Korek, J. (1991). Central nervous reactions of histamine 2 receptor antagonists system. Annals of Internal Medicine, 114, 1027-1034.

Carr A., & Frei, B. (1999). Vitamin C Act as a pro-oxidant under physiological conditions? Journal of the Federation of American Societies for Experimental Biology, 13, 1007-1024.

Cathcart, R. (1986). Treatment of vitamin C in allergy and defuses State normal antibodies. Medical Hypotheses, 21, 307-21.

Chen, G., Hasanat, K., Bebchuk, J., Moore, G., Clair, D., et al. (1999). Regulation of signal transduction pathways and gene expression with mood stabilizers and antidepressants. Psychosomatic Medicine, 61, 599-617.

Chen, K., Suh, J., Carr, A., Morrow, J., Zeind, J., et al. (2000). Vitamin C inhibits lipid oxidation in vivo damage, even in the presence of iron overload. American Journal of Physiology Endocrinology and Metabolism, 279, E1406-1412.

Cheung, W. (1970). Cyclic 3 ', 5'-nucleotide phosphodiesterase. Demonstration activator. Biochemical and Biophysical Research Communications, 38, 533-538.

Chiavegatto, S., Naselle, A., & Bernardi, M. (1998). Histamine and spontaneous motor activity: changes biphasic, receptors involved and participation of the dopaminergic system in the striatum. Life Sciences, 62, 1875-1888.

Chrousos, G. (2000). The stress response and immune function: clinical implications. Annals New York Academy Science, 917, 39-67.

Clemetson, C. (1999). The key role of histamine in the development of atherosclerosis and coronary heart disease. Medical Hypotheses, 52, 1-8.

From Chaffoy de Courcelles D., Leysen, J., De Clerck, F., Van Belle H., and Janssen, P. (1985). Evidence that phospholipid turnover is the intracellular signaling system coupled receptors serotonin S2. Journal of Biological Chemistry, 260, 7603-7608.

De Kloet, E., Sybesma, H. and Reul, H. (1986). Control selective receptor capacity of corticosterone serotonin1 in the system of the hippocampus-raphe. Neuroendocrinology, 42, 513-521.

Dinndorf, P., McCabe, M., & Frierdich, S. (1998). Risk of abuse of diphenhydramine in children and adolescents with chronic diseases. Journal of Pediatrics, 133, 293-295.

Edelman, E. (1998). Natural healing for schizophrenia and other mental disorders. Eugene: Books Borage.

Edelman, N. (1997). American Lung Association: family guide with asthma and allergies. New York: Time Life Media.

Feinstein, A. (1996). Healing with vitamins. Emmaus Rodale Books, Inc.

Fernandez-Novoa, L., and Cacabelos, R. (2001). function of histamine in brain disorders. Brain Behavior Research, 124, 213-233.

Firshein, R. (1996). Resumption of asthma. New York: Warner Books, Inc.

Fried, R. (1999). Breathe well, well. New York: John Wiley & Sons, Inc.

Friedman, E., Hoau, Y., Lavinson, D., Connell, T., Singh, H. (1993). Disruption of protein kinase C platelets bipolar disorder manic episode. Biological Psychiatry, 33, 520-525.

Galos, R., Lenard, L., Knoche, A., Haas, H., Huston, J., et al. (2001). dopaminergic effects of the administration of histamine in nucleus accumbens and the impact of H1-receptor blockade. Neuropharmacology, 40, 624-633.

Ginter, E. (1980). What is really the pool maximum body size ascorbic acid in man? American Journal of Clinical Nutrition, 33, 538-539.

Garcia, A. Carnahan, J., & Greenberg, M. (1994). Requirement for BDNF in activity dependent survival of cortical neurons. Science, 263, 1618-1623.

Glick S., & Crane, L. (1978). Similar to opioid withdrawal, the effects of intracerebral histamine administration in rats. Nature, 273, 547-549.

Goodman, A., Harman, J., Limbird, L., P. Molinoff, Ruddon, R., et al. (1996). The Pharmacological Basis of Therapeutics, 9th ed. New York: McGraw Hill.

Greengard P., Nairn, A., Girault, J., Ouimet, C., Snyder, et al. (1998). DARPP-32/protein-1 phosphatase cascade: a model for signal integration. Brain Research Reviews, 1998, 26, 274-284.

Greenwood, J. (1991). Mechanisms of the blood-brain barrier breakdown of blood. Neuroradiology, 33, 95-100.

Gruenwald, R. (1993). Ascorbic acid in the brain. Brain Research Reviews 18, 123-133.

Gutteridge, J. & Halliwell, B. (1996). The antioxidants in the diet health and disease. Oxford: Oxford University Press.

Haas, E. (1992). Staying Healthy with Nutrition. Berkeley: Celestial Arts Publishing.

Hagiwara M., Brindle P., Harootunian, A., Armstrong, R., Rivier, et al. (1993). Coupling of hormonal stimulation and the transcription factor cyclic AMP responding CREB is rate limited by nuclear entry of protein kinase A. Molecular Biology and Cell, 13, 4852-4859.

Halpert, A., Olmstead, M. & Beninger, R. (2002). Mechanisms and abuse against histamine dimenhydrinate. Neuroscience and Biobehavioral Reviews, 26, 61-67.

Hasenöhrl, R. Weth, K., & Huston, J. (1999). intraventricular infusion of histamine H (1) receptor antagonist chlorpheniramine improves maze performance and-as the effects of anxiety among nursing home 344xBrown Fischer hybrid Norway rats. Experimental Brain Research, 128, 435-440.

Hatta, S. Ozawa, H., Saito, T., & Ohshika, H. (1995). of tubulin in the regulation of adenylate cyclase stimulation in membranes of rat cerebral cortex involvement. Journal of Neurochemistry, 64, 1343-1350.

Hediger, M. (2002). New view at C. Nature Medicine, 8 445-446.

Heleniak, E., and O'Desky, I. (1999). Histamine and prostaglandins in schizophrenia: a review. Medical Hypotheses, 52, 37-42.

Hitomi, K., & Tsukagoshi, N. (1996). Role of ascorbic acid in the modulation of gene expression. Subcellular Biochemistry, 25, 41-56.

Hoffer A. & Walker, M. (1978). Put it all together: new orthomolecular nutrition. New Canaan: Keats Publishing, Inc.

Hook, S., and means, A. (2001). Ca2 + / CAM-dependent kinases: from activation to function. Annual Review of Pharmacology and Toxicology, 41, 471-505.

Horrobin, D. (1996). Ascorbic acid and prostaglandin synthesis. Subcellular Biochemistry, 25, 109-115.

Horstra, C., Desai, P., Thurmond, R., & Fung Leung, W. (2003). Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. Journal Pharmacology and Experimental Therapeutics, 305, 1212-1221.

Hoshi, M., Akiyama, T., Shinohara, Y. Miyata, Y., Ogawara, H., et al. (1988). phosphorylation of protein kinase C, catalyzed by the microtubule binding domain of microtubule-associated protein 2 inhibits its ability to induce polymerization of tubulin. European Journal of Biochemistry, 174, 225-230.

Hurwitz, E., and Morgenstern, H. (2001). Immediate and Long-term effects of immune stimulation: hypothesis linking the immune response to subsequent physical and psychological well-being. Medical Hypotheses, 56, 620-624.

Hyman C., Juhasz, M. Jackson, C., Wright, P., IP, N., and Lindsay, R. (1994). Overlapping and distinct actions of neurotrophins BDNF, NT-3 and NT-4 5 / culture and GABAergic neurons in the midbrain dopaminergic ventral. Journal of Neuroscience, 14, 335-347.

Ito, C. (2000). The role of histamine in the brain of acute and chronic stress. Biomedicine and Pharmacotherapy, 54, 263-267.

Jacob R. (1996). C three times the discovery of the vitamin. Subcellular Biochemistry, 25, 1-15.

Jacobs, E., Yamatodani, A., & Timmerman, H. (2000). Histamine final slide is a neurotransmitter of the circadian rhythms in mammals? TIPS, 21, 293-298.

Jameson, L., T. Frey, Zeeberg, B., Dalldorf, F., and Caplow, M. (1980). Inhibition of microtubule assembly by phosphorylation of proteins associated with microtubules. Biochemistry 19, 2472-2479.

Janson, M. (2000). Dr. Janson new vitamin revolution. New York: Avery Books.

Jensen, R. (2002). Chess American medicine. Victoria: Trafford Publishing.

Johnson, E., KAMILARI, T., Chrousos, G., & Gold, P. (1992). Mechanisms of stress: a dynamic vision of hormonal and behavioral homeostasis. Neuroscience and Biobehavioral Reviews, 16, 115-130.

Johnston, C., Martin, L, and Cai, X. (1992). antihistamine effect of additional ascorbic acid and chemotaxis of neutrophils. Journal of the American School of Nutrition, 11, 172-176.

Johnston, C., Retrum, K., & Srilakshmi, J. (1992). antihistamine effects and complications supplementation of vitamin C. Journal of the American Dietetic Association, 92, 988-989.

Johnston, C. (1996). Antihistamines Acting acid ascorbic. Subcellular Biochemistry, 25, 189-213.

Kagaya, A., & Yamawaki, S. (1998). Immunological aspects of mood disorders: interaction between cytokines and intracellular calcium signaling. In: Signal transduction in affective disorders. Tokyo: Springer-Verlag.

Kalives, P. (1982). Histamine-induced excitation and pentobarbital-pretreated conscious rats. Journal of Pharmacology and Therapeutics experimental, 222, 37-42.

Kallner, A. (1987). Requirement of vitamin C on the basis of studies of metabolism. Annals New York Academy of Sciences, 496, 418-423.

Kamei, C., & Tasaka, K. (1993). Effect of histamine on memory retrieval in old rats. Biological and Pharmaceutical Bulletin, 16, 128-132.

Katsuki, H. (1996). Vitamin C and nervous tissue: in vivo and in vitro aspects. Subcellular Biochemistry, 25, 293-311.

Katzung, B. (1998). Basic and Clinical Pharmacology 7th Ed New York: McGraw Hill.

Kilpelainen, M., Koskenvuo, M., Helenius, H. and Terho, E. (2002). Stressful events of life to promote the event and atopic diseases of asthma. Clinical and Experimental Allergy, 32, 256-263.

King, D. (1981). The Allergic reactions can cause psychological symptoms? A double-blind. Biological Psychiatry, 16, 3-19.

Kiyatkin, E., and Rabel G. (1998). Ascorbate module induced by stimulation of glutamate neurons in the striatum. Brain Research, 812, 14-22.

Klee, C., Ren, H. Wang, X (1998). Regulation of protein phosphatase-calmodulin stimulation, calcineurin. Journal of Biological Chemistry, 273, 13367-13370.

Knigge, U., & Wargberg, J. (1991). Neuroendocrine functions of histamine. consultative Agents Actions, 33, 29-53.

Knoche, A., Yokoyama, H., Ponomarenko, A., Frisch, C. Huston, J., & Haas, H. (2003). high frequency oscillation in the hippocampus of rats behavior and its modulation by the histaminergic system. Hippocampus, 13, 273-280.

Koenig, J. & Elmadfa, I. (1996). transport of ascorbic acid and availability. Subcellular Biochemistry 25, 136-155.

Komindr, S., Nichoalds, G., and Kitabchi, A. (1987). bimodal effects of megadoses of vitamin C in the production of adrenal steroids in humans: an in vivo study Annals. New York Academy of Sciences, 496, 487-490.

Koob, G. (1999). Stress, corticotropin-releasing factor, and substance abuse. Annals New York Academy Science, 897, 27-45.

Kurian, P., Chandler, J., Patel, R., and Crews, F. (1992). phosphoinositide-coupled receptor signals. In: Neurobiology of essential fatty acids. New York: Plenum Press.

Kusumi, I., Koyama, T., & Yamashita, I. (1991). Effect of various factors on serotonin-induced Ca2 + response in human platelets. Life Sciences, 48, 2405-2412.

Kusumi, I., and Koyama, T. (1998). Serotonin 2A receptor function in affective disorders. In: Signal transduction in affective disorders. Tokyo: Springer-Verlag.

Lader, M., & Scotto, JC. (1998). A multicenter double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder. Psychopharmacology, 139, 402-406.

Lakoski, J., & Aghajanian, G. (1983). Effects of histamine H1 and H2 antagonist-receptor activity of serotonergic neurons in the dorsal raphe nucleus. Journal of Pharmacology and Experimental Therapeutics, 227, 517-523.

Leurs, R., Remko Bakker, R., Timmerman, H., and Esch, I. (2005). The histamine H3 receptor: cloning of the gene H3 receptor drugs. Nature Reviews Drug Discovery, 4, 107-120.

Levine, M., & Morita, K. (1985). Ascorbic acid in endocrine systems. Vitamins and hormones, 42, 1-65.

Levine, M., & Hartzell, W. (1987). Ascorbic acid: the concept of optimum conditions. Annals of New York Academy Science, 496, 424-444.

Lewin, B. (1994). Genes V. New York: Oxford University Press.

Lieberman, S., & Bruning, N. (1997). The real vitamin and mineral reserves, 2nd ed .. Honesdale: Paragon Press.

Lintunen, M., Raatesalmi, K. Sallmen, T., Anichtchik, O., Karlstedt, K., et al. (2002). Low levels of histamine acts on the brain induced motor impairment from ethanol. Neurobiology of Disease, 9, 94-105.

Lisman, J. (1994). CaM kinase II hypothesis for the storage of synaptic memory. Trends Neuroscience, 17, 406-412.

Maes, M., De Ruyter, Hobin, P., & Suy, E. (1987). Relationship between the suppression test and dexamethasone Amino acids L-tryptophan/competing ratio in depression. Psychiatry Research, 21, 323-335.

Mamun, L. Blue, M., Siuciak, J., & Altar, C. (1995). BDNF promotes the survival and sprouting of serotonergic axons in rat brain. Journal of Neuroscience, 15, 7929-7939.

Marcos, V., and Mark J. (1989). Brain Power. Boston: Houghton Mifflin Company.

Martin, P. (1997). The spirit of healing. New York: Thomas Dunne Books.

Matsushita, M., & Nairn, A. (1999). Inhibition of protein Ca2 + / calmodulin-dependent kinase I cascade the cAMP-dependent protein kinase. Journal of Biological Chemistry, 274, 10086-10093.

May, J. (2002). Recycling of vitamin C by thioredoxin reductase of mammals. Methods of Enzymology, 347, 327-332.

Mazurkiewicz-Kwilecki, I. (1983). plasma corticosterone Brain-histamine interactions. Life Sciences, 32, 1099-1106.

McDonald, E., Mann, A., & Thomas, H. (1987). The Interferons as mediators of psychiatric morbidity: an investigation in a trial of recombinant interferon-in hepatitis-B carriers. Lancet, 21, 1175-1178.

Menkes, D., Rasenick, M. Wheeler, M. & Bitensky, M. (1983). Guanosine triphosphate activation of adenylate cyclase brain: short-term improvement antidepressant long. Science, 129, 65-67.

Meyers, D., Maloley, P., & Weeks, D. (1996). Security antioxidant vitamins. Archives of Internal Medicine, 13, 925-935.

Mohsenin, V., and Dubois, A. (1987). Vitamin C and respiratory tract. Annals New York Academy of Sciences, 496, 260-267.

Mrazek, D., Schuman, W., and Klinnert, M. (1998). The early onset of asthma: risk of emotional and behavioral difficulties. Journal of Psychology and Psychiatry, 39, 247-254.

Nandi, B., Subramanian, N., Majumder, A., & Chatterjee, I. (1974). Effect of ascorbic acid the detoxification of histamine under conditions of stress. Biochemical Pharmacology, 23, 643-647.

Nibuya, M., Nestler, E., and Duman, R. (1996). Chronic administration of antidepressants increases the expression of cAMP response element binding protein (CREB) in hippocampus rat. Journal of Neuroscience, 16, 2365-2372.

Nishiga, M., Fujii, Y., Konishi, M., Hoss, M., Chiaki, K. (2003). Effects of generation of histamine H1 receptor antagonist of the second active avoidance response in rats. Clinical and Experimental Pharmacology and Physiology, 30, 60-63.

Nishikimi, M., & Yagi, K. (1996). Biochemistry and molecular biology of ascorbic acid biosynthesis. Subcellular Biochemistry, 25, 17-39.

Nishizuka, Y. (1986). Studies and perspectives of protein kinase C. Science, 233, 305-312.

Nualart, F., Rivas, C. Montecinos, V., Godoy, A., Guaiquil, V., Golde, D., et al. (2003). Recycling of vitamin C by a side effect. Journal of Biological Chemistry, 278, 10128-10133.

Ossofsky, H. (1976). affective disorder and atopic and cyclic AMP. Comprehensive Psychiatry, 17, 335-346.

Paleologos, Cumming, R., & Lazarus, R. (1998). Cohort study of intake of vitamin C and cognitive impairment. American Journal of Epidemiology, 148, 45-50.

Parle, M., & Dhingra, D. (2003). Ascorbic acid: a promising memory-enhancer in mice. Journal of Pharmaceutical Sciences, 93, 129-135.

Parmentier R., Ohtsu, H., Djebbar Hanna, Z., J. Valatx, Watanabe, T., et al. Anatomically, pharmacological and physiological characteristics of histidine decarboxylase knock-out mice: evidence of the role of histamine in the brain and control sleep-wake behavior. (2002). Journal of Neuroscience, 22, 7695-7711.

Passani, M., Bacciottini, L., Mannaioni, P., and Blandina, P. (2000). Central histaminergic system and cognition. Neuroscience and Biobehavioral Reviews, 24, 107-113.

Passani, M., Line, JS., Hancock, A., Hook, S., and Blandina, P. (2004). The histamine H3 receptor as a new therapeutic target for sleep and cognitive disorders. Trends in science pharmacology, 25, 618-625.

Peitsaro, N., Käslin, J., Anichtchik, O., & Panula, P. (2003). Modulation of the histaminergic system and the behavior of alpha-fluoromethylhistidine zebrafish. Journal of Neurochemistry, 86, 432-441.

Perrig, W., Perrig, P. & Stahelin, H. (1997). The relationship between antioxidants and memory performance in old and very old. Journal of the American Geriatrics Society, 45, 718-724.

Petrie, W. & Ban, J. (1985). Vitamins in psychiatry: is there a role? Drugs 30, 58-65.

Pfeiffer C. (1987). Nutrition and mental illness. Rochester: Healing Arts Press.

Pilc, A., Rogoz, Z. and Skuza, G. (1982). Histidine-induced behavior strange in rats: possible role of central cholinergic system. Neuropharmacology, 21, 781-785.

Popoli M., Brunello N., Perez, J., & Racagni, G. (2000). Second Messenger regulated protein kinases in the brain: their functional role and the action of antidepressants. Journal of Neurochemistry, 74, 21-33.

Prast, H., Argyriou, A., & Philippu, A. (1996). Histaminergic neurons facilitate memory Social rats. Brain Research, 734, 316-318.

Raman, I., Tong, G., & Jahr, C. (1996). b-adrenergic receptor regulation Synaptic NMDA receptors by cAMP-dependent protein kinase. Neuron, 16, 415-421.

Reader's Digest Association. (1999). Healing The power of vitamins, minerals and herbs. Pleasantville: Reader's Digest Association.

Reavley N. (1998). The New Encyclopedia vitamins, minerals, supplements and herbs. New York: Bookman Press.

Rabel, G., and Pierce, R. (1994). Vitamin A as a neuromodulator: Release of ascorbate in the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Progress in Neurobiology 43, 537-565.

Rabel, G., and Wang, Z. (2001). behavioral activation in rats requires endogenous ascorbate release in the striatum. Journal of Neuroscience, 21, 668-675.

Rabel, G., Barton, S., Marseilles, A., & Collins, K. (2003). Ascorbate treatment attenuates the behavioral phenotype Huntington's mice. NeuroReport, 14, 1263-1265.

Repka-Ramirez, M., & Baraniuk, J. (2002). Histamine in health and disease. Allergy and Clinical Immunology, 17, 1-25.

Rice, M. (2000). Regulation of ascorbate and its neuroprotective effect in the brain. Trends in Neurosciences, 23, 209-216.

Rivers, J. (1987). Security Level C-sharp intake of vitamin. Annals New York Academy of Sciences, 496, 445-454.

Rogers, M., Bloomingdale, K. Murawski B., Soter, N., Reich, P., et al. (1986). Mixed organic brain syndrome as a manifestation of systemic mastocytosis. Psychosomatic Medicine, 48, 437-447.

Rose, R. (1988). The transport of ascorbic acid and other vitamins soluble in water. Biochem and Biophysica Acta, 947, 335-366.

Sakata, T., & Yoshimatsu, H. (1995). Homeostatic maintenance regulated by hypothalamic neuronal histamine. Methods of finding in experimental and clinical pharmacology, 17SC, 51-56.

Santos, N. J. Huston, Brandao, M. (2001). Escape behavior in the tonic inhibitory control of histamine H (2)-receptor mediated mechanisms on the roof of the midbrain. Behavioral Research Brain, 124, 167-175.

Sarri, E., Picatoste, F., and Claro, E. (1995). specific profiles of inositol phosphates of neurotransmitters in rat cerebral cortex: relationship with the mode of receptor activation of phosphoinositide phospholipase C. Journal Pharmacology and Experimental Therapeutics, 272, 77-84.

Schwaninger, M., R. Blume, Kruger, M., G. Lux, Oetjen, E., et al. (1995). Participation calcineurin-dependent gene transcription by Ca2 + is stimulated by cAMP through cAMP response elements. Journal of Biological Chemistry, 270, 8860-8866.

Shankaran, M., Yamamoto, B., & Gudelsky, G. (2001). Ascorbic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced hydroxyl radical formation and behavior and the consequences of the neurochemical depletion of brain 5-HT. Synapse, 40, 55-64.

Sharma, S., and Wilson, C. (1980). The cellular interaction of ascorbic acid with histamine, prostaglandins and nucleotides ring in the immediate hypersensitivity reaction. International Journal of vitamin and nutrition research, 50, 163-70.

Shelton, R., Maine, D., & Sulser, F. (1996). CAMP dependent protein kinase activity in major depression. American Journal of Psychiatry, 153, 1037-1042.

Shenolikar, S., and Nairn, A. (1991). Protein phosphatases: recent progress. Advances in second Messenger Phosphoprotein Research, 23, 1-121.

Shimizu, M., Nishida, A., Fukuda, H., Saito, H., and Yamawaki, S. (1994). Inhibitory effect of imipramine on depolarization-induced increase in intracellular Ca2 + of rat cortical neurons. European Journal of Pharmacology, 268, 65-71.

Silver, P., Sigg, E., and Moyer, J. (1986). Antidepressants and protein kinases: inhibition of phosphorylation of myosin Ca2 +-regulated by fluoxetine and iprindol. European Journal of Pharmacology, 121, 65-71.

Sloboda, R., Rudolph, S., Rosenbaum, J., & Greengard, P. (1975). Cyclic phosphorylation AMP-dependent endogenous microtubule associated proteins. Proceedings of the National Academy of Sciences USA, 72, 177-181.

Smith, M., Makino, S., Kvetnansky, R., & Post, R. (1995). Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. Journal of Neuroscience, 15, 1768-1777.

Smythies, J. (1998). Each person antioxidants Guide. London: Rutgers University.

Snodgrass, S. (1992). Vitamin neurotoxicity. Molecular Neurobiology, 92, 41-73.

Stabel, S., and Parker, P. (1991). The protein kinase C. Health Carlos III, 51, 71-95.

Steinman, L. (2004). Elaborate interactions between the immune and nervous systems. Nature Immunology, 5, 575-581.

Task Stevenson J., & TFS. (2003). Relationship between behavior and asthma in children with atopic dermatitis. Psychosomatic Medicine, 65, 971-975.

Subramanian, N. (1977). The brain of ascorbic acid and its importance in the metabolism of biogenic amines. Life Sciences, 20, 1479-1484.

Subramanian, N. Nandi, B., Majumber, K., & Chatterjee, I. (1974). Effect of ascorbic acid acid detoxification of histamine in rats and pigs under drug treated conditions pigs. Biochemical Pharmacology, 23, 637-641.

Taglialatela, M., Timmerman, H., and Annunziato, L. (2000). CNS and cardiotoxic potential effects of first generation antihistamines. TIPS 21, 52-56.

Takahashi, K., Suwa, H., Ishikawa, T. & Kotani, H. (2002). selective disruption of H3 receptors results in changes in brain histamine tone leading to a phenotype of obesity. Journal of Clinical Investigation, 110, 1791-1799.

Thomas T. Zemp & J. (1977). The inhibition of adenylate cyclase sensitive dopamine from rat brain striatal homogenates by ascorbic acid. Journal of Neurochemistry, 1977, 663-665.

Tisdale, M. (1975). Inhibition of adenosine 3'-5'-monophosphate in Walker carcinoma and dehydroascorbic acid ascorbic. Biochemical and Biophysical Research Communications, 62, 877-882.

Tolbert, L., Thomas, T., Middaugh, L., and Zemp, J. (1979). Effect of ascorbic acid on neurochemical, behavioral and physiological systems mediated by catecholamines. Life Sciences, 25, 2189-2195.

Tong, G., Pastor, D. & Jahr, C. (1995). Synaptic desensitization of NMDA receptors by calcineurin. Science, 267, 1510-1512.

Trax, O., Huet, B., Poindexter, J., Pak, C., & Pearle, M. (2003). Effect of ascorbic acid consumption on risk templates urinary stones. Journal of Urology, 170, 397-401.

Traynelis, S., and Wahl, P. (1997). Control of the glutamate receptor open probability rat GluR6 by protein kinase A and calcineurin. Journal of Physiology, 503, 513-531.

Tuomisto, J., & Männistö, P. (1985). the Neurotransmitter regulation of anterior pituitary hormones. Pharmacological Reviews, 37, 249-332.

Tuomisto, L. (1994). Regulation feeding behavior, with special reference to histamine. Journal of Physiology and Pharmacology, 45, 469-477.

Suede Van, B., and Kamphuis, H. (1984). Cimetidine neurotoxicity. EEG and behavioral aspects. European Neurology, 23, 300-305.

Vayda, W. (1994). Asthma Attack. Port Melbourne: Lothian Books.

Victor, M., & Ropper, A. (2001). Adams and Victor's principles of neurology, 7th ed. New York: McGraw-Hill.

Wachtel, H. (1982). Characteristic behavioral alterations in rats induced by rolipram and other selective cyclic adenosine 3 'monophosphate phosphodiesterase-5 inhibitors'. Psychopharmacology, 77, 309-316.

Wachtel, H. (1990). The second hypothesis dysbalance messenger affective disorders. Pharmacopsychiatry, 23, 27-32.

Wada, H., Inagaki, N., iTower, N., Yamatodani, A. (1991). histaminergic neuron system in the brain: distribution and possible functions. Brain Research Bulletin, 27, 367-370.

Wada, H., Inagaki, N., Yamatodani, A., and Watanabe, T. (1991). The system is a histamine-control center for the activity Brain-together? Enclosures, 14, 415-418.

Walaas, S., and Greengard, P. (1991). Protein phosphorylation and neuronal function. Pharmacological Reviews, 43, 299-349.

Washko, P., ROTRA, D., & Levine, M. (1991). Ascorbic acid in human neutrophils. American Journal of Clinical Nutrition, 54 (6 Suppl), 1221-1227.

Weinstein, A. (1987). Asthma: The Complete Guide for self-management of asthma and allergy patients and their families. New York: Fawcett Crest.

Willems, E., Knigge, U. Jorgensen, H., Kjaer, A., & Warberg, J. (1999). Effect of selective blockade of catecholaminergic alpha and beta receptors on histamine-induced release of corticotropin prolactin. Neuroendocrinology, 69, 309-315.

Wilson, B., Shannon, M., & Stang, C. (2000). Nurses Drug Guide Nurses: 2000. Stamford: Appleton and Lange.

Wilson, C. (1982). The appetite for vitamin C: its relationship with the potential energy Cell. International Journal of vitamins and supplements Nutrition Research, 23, 173-185.

Winder, D., Mansuy, I., Osman M., Moallem, T., & Kandel, E. (1998). Genetic and pharmacological data for a novel, intermediate phase of long-term empowerment suppressed by calcineurin. Cell, 92, 25-37.

Wolcott, W., and Fahey, T. (2002). The metabolic typing diet. New York: Broadway Books.

Wray, B. (1998). Take care of asthma: a strategy for life. New York: John Wiley & Sons, Inc.

Xu, D., & Wells, W. (1996). Regeneration of alpha-lipoic acid dependent ascorbic acid from dehydroascorbic in mitochondria rat liver. Journal of Bioenergetics and Biomembranes, 28, 77-85.

Yanai K., Son. L., Endou, M., Sakurai, E., Nakagawasai, O., and al. (1998a). Characterization and behavior of the quantity of brain monoamines and their metabolites in mice lacking histamine H1 receptors. Neuroscience, 87, 479-487.

Yanai K., Son, L., Endou, M., Sakurai, E., and Watanabe, T. (1998b). Targeting disruption of histamine H1 in mice: behavioral and neurochemical characterization. Life Sciences, 62, 1607-1610.

Young, L., Li, P., Kish, S., Siu, K. Kamble, A., et al. (1993). Cerebral Cortex GSA protein levels and forskolin stimulates formation of cyclic AMP are increased in affective disorders bipolar. Daily Neurochemistry, 61, 890-898.

Zafra F., Lindholm D., Castren, E., Hartikka, J., & Thoenes, H. (1992). settlement factor and brain-derived growth factor mRNA neurotrophic neurons in primary cultures of hippocampal neurons and astrocytes. Journal of Neuroscience, 12, 4793-4799.

Zanotti, S., Mori, S., Radaelli, A., Perez, J., Racagni, G., et al. (1998). Changes brain cAMP and calcium / calmodulin-Dependent Protein Kinases induced by treatment with S-adenosylmethionine. Neuropharmacology, 37, 1081-1089.

About the Author

Dr. Jensen is both a consultant and author in the BioMedical and Nutrition fields. He has previously written a book on both topics, The Failures of American Medicine, published in 2002. Dr. Jensen has also written a doctoral dissertation on how Vitamin C can reduce stress and allergies via its antihistamine effect. He has worked in a broad range of BioMedical fields, such as gene regulation, cancer research, and HIV vaccine development. However, Dr. Jensen eventually decided that helping people more directly would be more rewarding for everyone involved. He has since helped clients with dozens of different ailments. Dr. Jensen is a practitioner in the field of Metabolic Typing, which characterizes different biochemistries among people based on certain physical and behavioral traits they have.

You can contact Dr. Jensen at 1-800-390-5365, or mail him at drjensen@individualizednutrition.com.

50-Amp Power Supply Fully Regulated Pyramid #PS52KX $193.72

ASTRON RS-12A REGULATED POWER SUPPLY 9 AMPS 13.8 VDC $49.95

33 Amp 12 Volt DC 13.8V Regulated Power Supply 12V $58.00

2Amp security camera12V DC regulated power supply $9.50

Sorensen / Xantrex XTS 15-4 Regulated DC Power Supply 15Volt 4 Amp w/ M9B card $185.99

Sorensen / Xantrex XTS 7-6 Regulated DC Power Supply 7Volt 6 Amp w/ M9B card $185.99

12 Volt 33 Amp On-Board RV or Car Battery Charger Regulated Adjustable to 15V $54.00

HEWLETT PACKARD (HP) 6260B REGULATED DC POWER SUPPLY (0-10 Volt / 0-100 Amp) $439.20

NEW 14 Amp PYRAMID PS14KX AC/DC Regulated Power Supply $53.95

PMC POWER MATE REGULATED POWER SUPPLY 20 VOLT V 1.2 AMP A USED MADE IN USA $20.00

MASTECH HY3003D LINEAR REGULATED DC POWER SUPPLY VARIABLE 0-30 VOLTS @ 0-3 AMPS $89.95

MASTECH HY1503C LINEAR REGULATED DC POWER SUPPLY VARIABLE 0-15 VOLTS @ 0-3 AMPS $54.95

MASTECH HY3006D LINEAR DC POWER SUPPLY VARIABLE REGULATED 0-30 VOLTS @ 0-6 AMPS $119.95

MASTECH HY3006D REGULATED DC POWER SUPPLY 0-30 VOLTS @ 0-6 AMPS + HD LEADS $139.95

MASTECH LINEAR DC POWER SUPPLY REGULATED VARIABLE 0-30 VOLTS @ 0-20 AMPS $279.95

MASTECH HY3010D LINEAR REGULATED DC POWER SUPPLY VARIABLE 0-30 VOLTS @ 0-10 AMPS $189.95

MASTECH HY3020D REGULATED LINEAR DC POWER SUPPLY 0-30 VOLTS @ 0-20 AMPS $289.95

NEW MASTECH HY3006D LINEAR REGULATED DC POWER SUPPLY 0-30 VOLTS @ 0-6 AMPS $119.95

MASTECH HY3020D LINEAR REGULATED DC POWER SUPPLY 0-30 VOLTS @ 0-20 AMPS + LEADS $299.95

NEW 110V AC TO DC CONVERTER POWER SUPPLY 12V 15AMP FULLY REGULATED LOW RIPPLE $69.95

-More RF and Microwave Products-

50-Amp Power Supply Fully Regulated Pyramid #PS52KX $193.72

ASTRON RS-12A REGULATED POWER SUPPLY 9 AMPS 13.8 VDC $49.95

33 Amp 12 Volt DC 13.8V Regulated Power Supply 12V $58.00

2Amp security camera12V DC regulated power supply $9.50

Sorensen / Xantrex XTS 15-4 Regulated DC Power Supply 15Volt 4 Amp w/ M9B card $185.99

Sorensen / Xantrex XTS 7-6 Regulated DC Power Supply 7Volt 6 Amp w/ M9B card $185.99

12 Volt 33 Amp On-Board RV or Car Battery Charger Regulated Adjustable to 15V $54.00

HEWLETT PACKARD (HP) 6260B REGULATED DC POWER SUPPLY (0-10 Volt / 0-100 Amp) $439.20

NEW 14 Amp PYRAMID PS14KX AC/DC Regulated Power Supply $53.95

PMC POWER MATE REGULATED POWER SUPPLY 20 VOLT V 1.2 AMP A USED MADE IN USA $20.00

MASTECH HY3003D LINEAR REGULATED DC POWER SUPPLY VARIABLE 0-30 VOLTS @ 0-3 AMPS $89.95

MASTECH HY1503C LINEAR REGULATED DC POWER SUPPLY VARIABLE 0-15 VOLTS @ 0-3 AMPS $54.95

MASTECH HY3006D LINEAR DC POWER SUPPLY VARIABLE REGULATED 0-30 VOLTS @ 0-6 AMPS $119.95

MASTECH HY3006D REGULATED DC POWER SUPPLY 0-30 VOLTS @ 0-6 AMPS + HD LEADS $139.95

MASTECH LINEAR DC POWER SUPPLY REGULATED VARIABLE 0-30 VOLTS @ 0-20 AMPS $279.95

MASTECH HY3010D LINEAR REGULATED DC POWER SUPPLY VARIABLE 0-30 VOLTS @ 0-10 AMPS $189.95

MASTECH HY3020D REGULATED LINEAR DC POWER SUPPLY 0-30 VOLTS @ 0-20 AMPS $289.95

NEW MASTECH HY3006D LINEAR REGULATED DC POWER SUPPLY 0-30 VOLTS @ 0-6 AMPS $119.95

MASTECH HY3020D LINEAR REGULATED DC POWER SUPPLY 0-30 VOLTS @ 0-20 AMPS + LEADS $299.95

NEW 110V AC TO DC CONVERTER POWER SUPPLY 12V 15AMP FULLY REGULATED LOW RIPPLE $69.95

-More RF and Microwave Products-